Vins Bioproducts Limited — Antitoxin Exporter Profile
Indian Pharmaceutical Exporter · #1 for Antitoxin · $9.0M export value · DGFT Verified
Vins Bioproducts Limited is the #1 Indian exporter of Antitoxin with $9.0M in export value and 206 verified shipments. Vins Bioproducts Limited holds a 64.7% market share in Antitoxin exports across 37 countries. The company exports 3 pharmaceutical products worth $15.7M across 1 therapeutic categories.
Vins Bioproducts Limited — Antitoxin Export Profile: Buyers & Destinations
Where Does Vins Bioproducts Limited Export Antitoxin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| FRANCE | $2.6M | 66 | 47.1% |
| MOROCCO | $722.0K | 16 | 12.9% |
| INDONESIA | $398.3K | 8 | 7.1% |
| ALGERIA | $349.5K | 37 | 6.2% |
| SUDAN | $250.2K | 7 | 4.5% |
| SENEGAL | $200.0K | 4 | 3.6% |
| JORDAN | $157.0K | 5 | 2.8% |
| UKRAINE | $114.9K | 19 | 2.1% |
| COTE D IVOIRE | $100.0K | 2 | 1.8% |
| TUNISIA | $81.8K | 6 | 1.5% |
Vins Bioproducts Limited exports Antitoxin to 38 countries. The largest destination is FRANCE accounting for 47.1% of Vins Bioproducts Limited's Antitoxin shipments, followed by MOROCCO (12.9%) and INDONESIA (7.1%). These destinations reflect Vins Bioproducts Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Antitoxin from Vins Bioproducts Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| FPPGQ | FRANCE | $550.0K | 11 |
| CUST ID:FPPGQ | FRANCE | $465.9K | 13 |
| PLANET PHARMA | FRANCE | $300.0K | 6 |
| CUST ID: FPPGQ | FRANCE | $294.8K | 11 |
| PLANET PHRAMA | FRANCE | $200.0K | 4 |
| CUST ID :- CMN IPDM 002 | MOROCCO | $200.0K | 4 |
| CUST ID FPPGQ PLANET PHARMA ZAC DU GRAND | FRANCE | $150.0K | 3 |
| CUST ID:MLDPI | MOROCCO | $150.0K | 3 |
| AEIC MIDEXPRESS ORLY, | FRANCE | $150.0K | 3 |
| CUST ID:SFSMN | SUDAN | $100.2K | 4 |
Vins Bioproducts Limited supplies Antitoxin to 102 buyers globally. The largest buyer is FPPGQ (FRANCE), followed by CUST ID:FPPGQ (FRANCE) and PLANET PHARMA (FRANCE). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Antitoxin Export Value and How Much Does Vins Bioproducts Limited Contribute?
India exported $13.2M worth of Antitoxin through 524 shipments from 45 suppliers to 80 countries, serving 238 buyers globally. Vins Bioproducts Limited contributes $9.0M to this total, accounting for 64.7% of India's Antitoxin exports. Vins Bioproducts Limited ships Antitoxin to 38 countries through 102 buyers.
What Is the Average Shipment Value for Vins Bioproducts Limited's Antitoxin Exports?
Vins Bioproducts Limited's average Antitoxin shipment value is $43.7K per consignment, based on 206 shipments totaling $9.0M. The largest destination is FRANCE (47.1% of Vins Bioproducts Limited's Antitoxin exports).
How Does Vins Bioproducts Limited Compare to Other Indian Antitoxin Exporters?
Vins Bioproducts Limited ranks #1 among 45 Indian Antitoxin exporters with a 64.7% market share. The top 3 exporters are VINS BIOPRODUCTS LIMITED ($8.6M), PREMIUM SERUMS AND VACCINES PRIVATE LIMITED ($1.4M), SERUM INSTITUTE OF INDIA PRIVATE LIMITED ($999.9K). Vins Bioproducts Limited processed 206 shipments to 37 destination countries.
What Antitoxin Formulations Does Vins Bioproducts Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| TETANUS ANTITOXIN 1500 IU IP PFS (TETAVI | $610.1K | 13 |
| TETANUS ANTITOXIN IHS/BP 1500 IU/ML | $294.4K | 9 |
| DIPHTHERIA ANTITOXIN 10,000 IU BP (LIQUI | $200.0K | 4 |
| ANTITOXINE TETANIQUE 1500 UI BP Solution(TETANUS ANTITOXIN I.H.S B.P 1500 IU /ML (IN PFS VIALS AMPOULE) (TETAVIN) (FOC | $200.0K | 4 |
| TETANUS ANTITOXIN 1500 IU IP PFS(TETAVIN) | $187.1K | 4 |
| TETANUS ANTITOXIN 1500 IU IP PFS TETAVIN | $154.4K | 4 |
| TETANUS ANTITOXIN IHS/BP 1500 IU/ML (QTY60 VIALS IS FREE OF COST FOR TESTING PURPOSE ONLY) | $150.0K | 3 |
| TETANUS ANTITOXIN 1500 IU PFS (TETAVIN)BATCH NO:44AT24028, 44AT24029,44AT25001 | $150.0K | 3 |
| TETANUS ANTITOXIN IHS/1ML-LIQUIDVLS | $132.6K | 6 |
| SNAKE VENOM ANTITOXIN (BIOSNAKE) LYOPHIL | $118.0K | 4 |
Vins Bioproducts Limited exports 142 distinct Antitoxin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is TETANUS ANTITOXIN 1500 IU IP PFS (TETAVI with 13 shipments worth $610.1K.
How Does Vins Bioproducts Limited Compare to Nearest Antitoxin Exporters?
Exporters ranked immediately above and below #1 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | VINS BIOPRODUCTS LIMITED ★ | $8.6M | 206 | 37 | $41.9K |
| 2 | PREMIUM SERUMS AND VACCINES PRIVATE LIMITED | $1.4M | 71 | 19 | $19.0K |
| 3 | SERUM INSTITUTE OF INDIA PRIVATE LIMITED | $999.9K | 62 | 23 | $16.1K |
Vins Bioproducts Limited ranks #1 among 45 Indian Antitoxin exporters. Average shipment value of $41.9K compared to the market average of $292.9K. The closest competitors by value are PREMIUM SERUMS AND VACCINES PRIVATE LIMITED and SERUM INSTITUTE OF INDIA PRIVATE LIMITED.
Which Indian Ports Ship Antitoxin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 125 | 23.9% |
| HYDERABAD ACC (INHYD4) | 99 | 18.9% |
| HYDERABAD AIR | 87 | 16.6% |
| SAHAR AIR | 74 | 14.1% |
| Bombay Air | 33 | 6.3% |
| Hyderabad Air | 25 | 4.8% |
| HYDERABAD ICD | 12 | 2.3% |
| DELHI AIR | 12 | 2.3% |
What Other Other Products Does Vins Bioproducts Limited Export?
Vins Bioproducts Limited also exports these other products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Vins Bioproducts Limited's Antitoxin Exports
Recent geopolitical developments have introduced significant challenges for Indian pharmaceutical exporters like Vins Bioproducts. The Israel-Iran conflict has disrupted Red Sea shipping routes, leading to increased freight costs and extended delivery times. These disruptions are particularly impactful for time-sensitive biologic products, where delays can compromise product efficacy. (pharmaceuticalcommerce.com)
In the United States, the imposition of tariffs on pharmaceutical imports has created an uncertain trade environment. Although generic drugs have been exempted from these tariffs as of October 2025, the initial imposition had already caused market volatility and necessitated strategic adjustments by exporters. (medboundtimes.com)
The European Union's stringent regulatory frameworks, including the Falsified Medicines Directive, demand rigorous compliance from exporters. For Vins Bioproducts, maintaining adherence to these evolving standards is crucial to sustaining and expanding its market presence in Europe.
Vins Bioproducts Limited — Regulatory Compliance & Quality Standards
The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with agencies like the US FDA intensifying inspections to ensure compliance with Good Manufacturing Practices (GMP). For Indian exporters, including Vins Bioproducts, this necessitates continuous investment in quality systems and infrastructure to meet international standards. (fact.net.in)
Vins Bioproducts' commitment to quality is evident in its state-of-the-art manufacturing facilities and adherence to international norms. This dedication not only facilitates access to regulated markets but also enhances the company's reputation as a reliable supplier of critical biologic therapies.
About Vins Bioproducts Limited
Vins Bioproducts Limited exports 3 products worth $15.7M. Beyond Antitoxin, top products include Serum, Immunoglobulin. View the complete Vins Bioproducts Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Antitoxin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Antitoxin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Vins Bioproducts Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 225 individual customs records matching Vins Bioproducts Limited exporting Antitoxin, covering 142 formulations to 38 countries via 102 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 80+ countries, 238+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Antitoxin Export Data from Vins Bioproducts Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Vins Bioproducts Limited's Antitoxin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Vins Bioproducts Limited
Full Company Profile →
3 products · $15.7M total trade · 1 categories
Antitoxin Stats
Company Overview
Top Products by Vins Bioproducts Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Vins Bioproducts Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Antitoxin. For current shipment-level data, contact TransData Nexus.